$FORA
Forian Inc.

2024 Q1 Form 10-K Financial Statement

#000114036124016673 Filed on March 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $4.877M $5.369M $20.48M
YoY Change 0.14% -32.07% -26.87%
Cost Of Revenue $1.703M $1.586M $5.477M
YoY Change 36.03% -7.81% -20.33%
Gross Profit $3.174M $3.783M $15.00M
YoY Change -12.28% -38.82% -29.0%
Gross Profit Margin 65.08% 70.47% 73.26%
Selling, General & Admin $4.548M $4.378M $18.87M
YoY Change -5.96% -30.8% -28.53%
% of Gross Profit 143.28% 115.71% 125.75%
Research & Development $389.9K $306.9K $1.408M
YoY Change -26.67% -87.62% -88.6%
% of Gross Profit 12.28% 8.11% 9.38%
Depreciation & Amortization $8.887K $14.44K $74.44K
YoY Change -76.87% -98.28% -97.43%
% of Gross Profit 0.28% 0.38% 0.5%
Operating Expenses $4.937M $4.695M $20.35M
YoY Change -8.02% -51.32% -47.48%
Operating Profit -$1.772M -$911.4K -$5.345M
YoY Change -25.77% -73.66% -79.51%
Interest Expense $199.0K $457.0K $7.299M
YoY Change -4.55% 726.61% 735.77%
% of Operating Profit
Other Income/Expense, Net $662.3K -$100.00 $3.980K
YoY Change 292.09% -100.46% -97.15%
Pretax Income -$1.110M -$454.6K $1.819M
YoY Change -49.97% -87.21% -107.01%
Income Tax $102.5K -$73.55K $85.74K
% Of Pretax Income 4.71%
Net Earnings -$1.213M $1.389M $11.11M
YoY Change -118.66% -139.05% -142.76%
Net Earnings / Revenue -24.86% 25.87% 54.23%
Basic Earnings Per Share -$0.04 $0.34
Diluted Earnings Per Share -$0.04 $0.04 $0.34
COMMON SHARES
Basic Shares Outstanding 31.13M 30.98M 32.03M
Diluted Shares Outstanding 31.00M 32.23M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.43M $48.34M $48.34M
YoY Change 18.57% 133.34% 133.34%
Cash & Equivalents $1.029M $6.043M
Short-Term Investments $46.41M $42.30M $42.30M
Other Short-Term Assets $2.437M $5.239M $5.239M
YoY Change 459.33% 1111.71% 274.42%
Inventory
Prepaid Expenses $868.5K $1.077M
Receivables $4.268M $3.700M $3.700M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $56.03M $57.28M $57.28M
YoY Change 1.3% 112.8% 112.8%
LONG-TERM ASSETS
Property, Plant & Equipment $67.20K $86.75K $86.75K
YoY Change -40.05% -96.63% -97.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.391M $1.524M $1.524M
YoY Change 666.42% 496.88% 496.88%
Total Long-Term Assets $1.463M $1.611M $1.611M
YoY Change 356.0% -91.67% -91.67%
TOTAL ASSETS
Total Short-Term Assets $56.03M $57.28M $57.28M
Total Long-Term Assets $1.463M $1.611M $1.611M
Total Assets $57.50M $58.89M $58.89M
YoY Change 3.34% 27.3% 27.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $374.7K $161.6K $161.6K
YoY Change 6.83% -71.9% -71.9%
Accrued Expenses $3.236M $4.263M $4.263M
YoY Change -49.63% -3.74% -9.19%
Deferred Revenue $2.852M $2.414M
YoY Change -8.01% -21.6%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.469M $6.839M $6.839M
YoY Change -34.71% -18.13% -18.13%
LONG-TERM LIABILITIES
Long-Term Debt $23.98M $24.87M $24.87M
YoY Change -5.27% -0.94% -0.94%
Other Long-Term Liabilities $500.0K $1.000M $1.000M
YoY Change 9176.44% 165.55% 165.55%
Total Long-Term Liabilities $24.48M $25.87M $25.87M
YoY Change -3.31% 1.52% 1.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.469M $6.839M $6.839M
Total Long-Term Liabilities $24.48M $25.87M $25.87M
Total Liabilities $30.95M $32.71M $32.71M
YoY Change -12.14% -3.33% -3.33%
SHAREHOLDERS EQUITY
Retained Earnings -$48.90M -$47.69M
YoY Change -6.49% -18.89%
Common Stock $31.09K $30.92K
YoY Change -4.09% -4.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $26.54M $26.18M $26.18M
YoY Change
Total Liabilities & Shareholders Equity $57.50M $58.89M $58.89M
YoY Change 3.34% 27.3% 27.3%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.213M $1.389M $11.11M
YoY Change -118.66% -139.05% -142.76%
Depreciation, Depletion And Amortization $8.887K $14.44K $74.44K
YoY Change -76.87% -98.28% -97.43%
Cash From Operating Activities -$2.208M -$601.2K $728.8K
YoY Change 79.75% -376.15% -108.31%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$4.510K $75.49K
YoY Change -100.0% -129.06% -95.59%
Acquisitions
YoY Change
Other Investing Activities -$1.774M $4.755M $7.195M
YoY Change 218.28% 204.54% -251.5%
Cash From Investing Activities -$1.774M $4.760M $7.120M
YoY Change 180.32% 207.89% -210.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$3.450M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.031M -3.492M -4.602M
YoY Change 990.25% 11808.32% 4477.35%
NET CHANGE
Cash From Operating Activities -2.208M -601.2K 728.8K
Cash From Investing Activities -1.774M 4.760M 7.120M
Cash From Financing Activities -1.031M -3.492M -4.602M
Net Change In Cash -5.014M 667.2K 3.247M
YoY Change 156.33% -61.53% -121.16%
FREE CASH FLOW
Cash From Operating Activities -$2.208M -$601.2K $728.8K
Capital Expenditures $0.00 -$4.510K $75.49K
Free Cash Flow -$2.208M -$596.7K $653.3K
YoY Change 69.34% -395.12% -106.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-transform: none;">Reclassifications </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </div> <div style="display:none;"><br/></div> <div style="text-align: left; text-indent: 35.8pt; margin-left: 0.2pt; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications have been made to the prior period financial statements to conform to the current period financial statement presentation. <span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain personnel, information licensing and data processing costs that were previously classified in research and development expenses when the Company’s healthcare information business was in its start-up stage were reclassified to cost of revenues and general and administrative expenses in the consolidated statements of operations.</span><br/> </div>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Customer Concentration</div> <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"> <br/> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"> During the <span style="color: rgb(0, 0, 0);">year ended December 31, 2023</span>, the Company has<span style="color: rgb(0, 0, 0);"> </span>two<span style="color: rgb(0, 0, 0);"> customers representing 13.1% and 12.0%</span> of revenue.<span style="color: rgb(0, 0, 0);"> </span>At <span style="color: rgb(0, 0, 0);">December 31, 2023</span> the Company had two customers representing 15.8% and 15.1% of accounts receivable.</div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none; text-indent: 36pt;"> <br/> </div> <div style="display:none;"><br/></div> <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">During the year ended <span style="color: rgb(0, 0, 0);">December 31, 2022</span>, the Company had two customers representing <span style="color: rgb(0, 0, 0);">11.5% and 14.3%</span> of revenue. At <span style="color: rgb(0, 0, 0);">December 31, 2022</span> the Company had three customers representing 25.9%, 14.8% and 14.6% of accounts receivable.</div>
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
167781
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
168070
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91696
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93040
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76085
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75030
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001829280
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40146
CY2023 dei Entity Registrant Name
EntityRegistrantName
FORIAN INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3467693
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
41 University Drive
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Newtown
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18940
CY2023 dei City Area Code
CityAreaCode
267
CY2023 dei Local Phone Number
LocalPhoneNumber
225-6263
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value per Share
CY2023 dei Trading Symbol
TradingSymbol
FORA
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
40000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31131835
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
San Jose, California
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6042986
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2795743
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42296589
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
17396487
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2572931
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1809028
CY2023Q4 fora Proceeds Receivable From Sale Of Discontinued Operations Net
ProceedsReceivableFromSaleOfDiscontinuedOperationsNet
1645954
CY2022Q4 fora Proceeds Receivable From Sale Of Discontinued Operations Net
ProceedsReceivableFromSaleOfDiscontinuedOperationsNet
0
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1126713
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2252958
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1077233
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
835786
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2515509
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
432338
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1393688
CY2023Q4 us-gaap Assets Current
AssetsCurrent
57277915
CY2022Q4 us-gaap Assets Current
AssetsCurrent
26916028
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76085
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75030
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10664
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32560
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1523948
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
196675
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
19037874
CY2023Q4 us-gaap Assets
Assets
58888612
CY2022Q4 us-gaap Assets
Assets
46258167
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
161590
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
316105
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
26179806
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12422476
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58888612
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4252257
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3766789
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10664
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21600
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
563
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
4547
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2413551
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2581287
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1662247
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6838625
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8352575
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1000000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10960
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
24870181
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
25106547
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
365609
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25870181
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25483116
CY2023Q4 us-gaap Liabilities
Liabilities
32708806
CY2022Q4 us-gaap Liabilities
Liabilities
33835691
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30920450
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30920450
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32251326
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32251326
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
30920
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
32251
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73834300
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
71182326
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47685414
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58792101
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-25971971
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.6
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46258167
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20481330
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16418141
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5477032
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5049701
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1407580
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4009769
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4884267
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3949026
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13633193
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16879858
CY2023 fora Separation Expenses
SeparationExpenses
599832
CY2022 fora Separation Expenses
SeparationExpenses
5417043
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
74438
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
65554
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
26076342
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
35370951
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-5595012
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-18952810
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3984
CY2022 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
364687
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
2327974
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
266213
CY2023 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
5805858
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
CY2023 us-gaap Interest Expense
InterestExpense
834785
CY2022 us-gaap Interest Expense
InterestExpense
846100
CY2023 fora Gain Loss On Redemption Of Debt
GainLossOnRedemptionOfDebt
111151
CY2022 fora Gain Loss On Redemption Of Debt
GainLossOnRedemptionOfDebt
0
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7414182
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-215200
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1819170
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19168010
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85740
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23980
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1733430
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-19191990
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-94427
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-6812913
CY2023 fora Discontinued Operation Gain On Sale Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainOnSaleOfDiscontinuedOperationBeforeIncomeTax
11531849
CY2022 fora Discontinued Operation Gain On Sale Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainOnSaleOfDiscontinuedOperationBeforeIncomeTax
32932
CY2023 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
2064165
CY2022 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
9373257
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6779981
CY2023 us-gaap Net Income Loss
NetIncomeLoss
11106687
CY2023 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
5805858
CY2022 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
CY2023 fora Gain Loss On Redemption Of Debt
GainLossOnRedemptionOfDebt
111151
CY2022 fora Gain Loss On Redemption Of Debt
GainLossOnRedemptionOfDebt
0
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
6573969
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
11920575
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.29
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.21
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.6
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.29
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.21
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32030855
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32031096
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32230845
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32031096
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12422476
CY2023 fora Stock Issued During Period Value Restricted Stock And Stock Awards Vesting Net Of Shares Surrendered For Taxes
StockIssuedDuringPeriodValueRestrictedStockAndStockAwardsVestingNetOfSharesSurrenderedForTaxes
-191465
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3484554
CY2023 fora Stock Issued During Period Value Common Stock Exercise Of Stock Options
StockIssuedDuringPeriodValueCommonStockExerciseOfStockOptions
0
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6326662
CY2023 us-gaap Net Income Loss
NetIncomeLoss
11106687
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
26179806
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25171265
CY2022 fora Stock Issued During Period Value Restricted Stock And Stock Awards Vesting Net Of Shares Surrendered For Taxes
StockIssuedDuringPeriodValueRestrictedStockAndStockAwardsVestingNetOfSharesSurrenderedForTaxes
-87406
CY2022 fora Stock Issued During Period Value Common Stock Exercise Of Stock Options
StockIssuedDuringPeriodValueCommonStockExerciseOfStockOptions
0
CY2022 fora Stock Issued During Period Value Common Stock Exercise Of Warrants
StockIssuedDuringPeriodValueCommonStockExerciseOfWarrants
0
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13310588
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-25971971
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
12422476
CY2023 us-gaap Net Income Loss
NetIncomeLoss
11106687
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-25971971
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
9373257
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6779981
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1733430
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-19191990
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74438
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
65554
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
21896
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1627
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5333
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5333
CY2023 fora Amortization Of Discount Proceeds From Sale Of Discontinued Operations
AmortizationOfDiscountProceedsFromSaleOfDiscontinuedOperations
389288
CY2022 fora Amortization Of Discount Proceeds From Sale Of Discontinued Operations
AmortizationOfDiscountProceedsFromSaleOfDiscontinuedOperations
0
CY2023 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
829452
CY2022 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
840767
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1876085
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
265443
CY2023 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3984
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-364687
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
763903
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
775451
CY2023 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1126245
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1196067
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
241447
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2382
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21896
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
28911
CY2023 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
1520022
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-496485
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-154521
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-131368
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
479021
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
548634
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-167736
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1943724
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1000000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
CY2023 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
787893
CY2022 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6071014
CY2023 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-59075
CY2022 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2510160
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
728818
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8581174
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
75493
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47678
CY2023 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
144077731
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
55819346
CY2023 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
121053714
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
51087663
CY2023 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
5805858
CY2022 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0
CY2023 fora Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
24413595
CY2022 fora Proceeds From Sale Of Discontinued Operations
ProceedsFromSaleOfDiscontinuedOperations
-17906
CY2023 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
7119943
CY2022 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4797267
CY2023 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
0
CY2022 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-1663778
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7119943
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6461045
CY2023 fora Payments On Notes Payable And Financing Arrangements
PaymentsOnNotesPayableAndFinancingArrangements
0
CY2022 fora Payments On Notes Payable And Financing Arrangements
PaymentsOnNotesPayableAndFinancingArrangements
13122
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
191465
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
87406
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3450053
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
960000
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-4601518
CY2022 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-100528
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4601518
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-100528
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3247243
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15142747
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2795743
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17938490
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6042986
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2795743
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4066385
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18444
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Use of Estimates</div> <div style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><br/> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses together with amounts disclosed in the related notes to the financial statements. The significant areas of estimation include but are not limited to accounting for the allowance for credit losses, income taxes, depreciation, amortization of intangible assets, contingencies, discontinued operations and stock-based compensation. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is possible that the external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</div>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2023 fora Number Of Monthly Payments Pending
NumberOfMonthlyPaymentsPending
2
CY2023Q4 fora Receivables From Sale Of Discontinued Operations Net
ReceivablesFromSaleOfDiscontinuedOperationsNet
1666667
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20712
CY2023 fora Amortization Of Discount Proceeds From Sale Of Discontinued Operations
AmortizationOfDiscountProceedsFromSaleOfDiscontinuedOperations
389288
CY2023 fora Discount In Interest And Investment Income Proceeds From Sale Of Discontinued Operations
DiscountInInterestAndInvestmentIncomeProceedsFromSaleOfDiscontinuedOperations
410000
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q3 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
5805858
CY2023Q3 fora Maximum Earnout Payments To Be Received
MaximumEarnoutPaymentsToBeReceived
3600000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1056891
CY2022 fora Contract With Customer Asset Deferred Revenue Recognized
ContractWithCustomerAssetDeferredRevenueRecognized
0
CY2022 fora Contract With Customer Asset Net Change Due To Timing Of Billings Payments And Recognition
ContractWithCustomerAssetNetChangeDueToTimingOfBillingsPaymentsAndRecognition
1196067
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2252958
CY2023 fora Contract With Customer Asset Deferred Revenue Recognized
ContractWithCustomerAssetDeferredRevenueRecognized
0
CY2023 fora Contract With Customer Asset Net Change Due To Timing Of Billings Payments And Recognition
ContractWithCustomerAssetNetChangeDueToTimingOfBillingsPaymentsAndRecognition
-1126245
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1126713
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P36M
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17202223
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15790233
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20831200
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
22192028
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
38033423
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
37982261
CY2023 fora Number Of Vendors
NumberOfVendors
2
CY2023 us-gaap Advertising Expense
AdvertisingExpense
56800
CY2022 us-gaap Advertising Expense
AdvertisingExpense
10563
CY2022Q2 fora Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized And Reserved For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAndReservedForIssuance
4000000
CY2022Q2 fora Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized And Reserved For Issuance Period Increase
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAndReservedForIssuancePeriodIncrease
2400000
CY2022Q2 fora Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized And Reserved For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAndReservedForIssuance
6400000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85740
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23980
CY2023 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
2064165
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.15
CY2022Q3 fora Effective Income Tax Excise Tax Rate
EffectiveIncomeTaxExciseTaxRate
0.01
CY2022Q1 fora Number Of Advisors
NumberOfAdvisors
2
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
366166
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
732332
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5417043
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1077233
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
835786
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1546614
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2077232
CY2023Q4 fora Information Contracts Of Vendors And Licensors
InformationContractsOfVendorsAndLicensors
1533861
CY2022Q4 fora Information Contracts Of Vendors And Licensors
InformationContractsOfVendorsAndLicensors
0
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1171782
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1689557
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4252257
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3766789
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
50954
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
92058
CY2023 fora Warrants Expired During Period Shares
WarrantsExpiredDuringPeriodShares
51102
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
281494
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.53
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.62
CY2023 fora Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingStock
349832
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
366166
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
732332
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5417043
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11359575
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y29D
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6573969
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11920575
CY2023 fora Share Based Payment Arrangement Expense From Discontinued Operations
ShareBasedPaymentArrangementExpenseFromDiscontinuedOperations
-247308
CY2022 fora Share Based Payment Arrangement Expense From Discontinued Operations
ShareBasedPaymentArrangementExpenseFromDiscontinuedOperations
1390013
CY2023 fora Share Based Compensation Including Discontinued Operations
ShareBasedCompensationIncludingDiscontinuedOperations
6326661
CY2022 fora Share Based Compensation Including Discontinued Operations
ShareBasedCompensationIncludingDiscontinuedOperations
13310588
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3139
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
972567
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1733430
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-19191990
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
9373257
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6779981
CY2023 us-gaap Net Income Loss
NetIncomeLoss
11106687
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-25971971
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.6
CY2023 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.29
CY2022 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.21
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1733430
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-19191990
CY2023 fora Income Loss From Continuing Operations After Effect Of Assumed Conversions
IncomeLossFromContinuingOperationsAfterEffectOfAssumedConversions
1733430
CY2022 fora Income Loss From Continuing Operations After Effect Of Assumed Conversions
IncomeLossFromContinuingOperationsAfterEffectOfAssumedConversions
-19191990
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
9373257
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6779981
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32030855
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32031096
CY2023 fora Incremental Common Shares Attributable To Conversion Of Restricted Stock Awards And Stock Options
IncrementalCommonSharesAttributableToConversionOfRestrictedStockAwardsAndStockOptions
199990
CY2022 fora Incremental Common Shares Attributable To Conversion Of Restricted Stock Awards And Stock Options
IncrementalCommonSharesAttributableToConversionOfRestrictedStockAwardsAndStockOptions
0
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32230845
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32031096
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.6
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.29
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.21
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6135184
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7089682
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1604676
CY2023Q4 us-gaap Share Price
SharePrice
2.15
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3450053
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
1819170
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-19168010
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1819170
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19168010
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7348
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
78392
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
23980
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
85740
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23980
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85740
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23980
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0063
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0034
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
2.6039
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Disposition Of Business
EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
0.0089
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.129
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0749
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0446
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.0087
CY2023 fora Effective Income Tax Rate Reconciliation True Up And Other
EffectiveIncomeTaxRateReconciliationTrueUpAndOther
-0.3824
CY2022 fora Effective Income Tax Rate Reconciliation True Up And Other
EffectiveIncomeTaxRateReconciliationTrueUpAndOther
-0.0044
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2.4677
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2854
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0419
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0013
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
21421
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
49827
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
237689
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
357441
CY2023Q4 fora Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
2910
CY2022Q4 fora Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
9007
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2028170
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5514035
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3380
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
10813
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
56882
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
65021
CY2023Q4 fora Deferred Tax Assets Capitalized Of Expenses Incurred To Research And Experimentation Activities
DeferredTaxAssetsCapitalizedOfExpensesIncurredToResearchAndExperimentationActivities
1138021
CY2022Q4 fora Deferred Tax Assets Capitalized Of Expenses Incurred To Research And Experimentation Activities
DeferredTaxAssetsCapitalizedOfExpensesIncurredToResearchAndExperimentationActivities
914390
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
5140001
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10517739
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8607053
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17459694
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8119492
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17332381
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
487561
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
127313
CY2023Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
29302
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
43741
CY2023Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
1951
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
74565
CY2023Q4 fora Deferred Tax Liabilities Installment Sale Receivable
DeferredTaxLiabilitiesInstallmentSaleReceivable
453398
CY2022Q4 fora Deferred Tax Liabilities Installment Sale Receivable
DeferredTaxLiabilitiesInstallmentSaleReceivable
0
CY2023Q4 fora Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
2910
CY2022Q4 fora Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
9007
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
487561
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
127313
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8119492
CY2023 fora Number Of Short Term Leases
NumberOfShortTermLeases
2
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
22374
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
1800
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10664
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
21600
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M23D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.095
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.093
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
22374
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1800
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
27833
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
46693
CY2023 us-gaap Lease Cost
LeaseCost
50207
CY2022 us-gaap Lease Cost
LeaseCost
48493
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10962
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
298
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10664
CY2023Q4 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
3245250
CY2023Q4 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
3652500
CY2023Q4 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
2854641
CY2023Q4 fora Other Commitment Due After Third Year
OtherCommitmentDueAfterThirdYear
5077184
CY2023Q4 us-gaap Other Commitment
OtherCommitment
14829575
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001140361-24-016673-index-headers.html Edgar Link pending
0001140361-24-016673-index.html Edgar Link pending
0001140361-24-016673.txt Edgar Link pending
0001140361-24-016673-xbrl.zip Edgar Link pending
ef20015361_10k.htm Edgar Link pending
ef20015361_ex19.htm Edgar Link pending
ef20015361_ex21.htm Edgar Link pending
ef20015361_ex23-1.htm Edgar Link pending
ef20015361_ex31-1.htm Edgar Link pending
ef20015361_ex31-2.htm Edgar Link pending
ef20015361_ex32-1.htm Edgar Link pending
ef20015361_ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fora-20231231.xsd Edgar Link pending
image00001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fora-20231231_cal.xml Edgar Link unprocessable
fora-20231231_def.xml Edgar Link unprocessable
fora-20231231_lab.xml Edgar Link unprocessable
fora-20231231_pre.xml Edgar Link unprocessable
ef20015361_10k_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending